Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?

被引:127
|
作者
Lahmame, A
delArco, C
Pazos, A
Yritia, M
Armario, A
机构
[1] UNIV AUTONOMA BARCELONA,FAC CIENCIES,UNITAT FISIOL ANIM,DEPT BIOL CELLULAR & FISIOL,BELLATERRA 08193,BARCELONA,SPAIN
[2] UNIV CANTABRIA,FAC MED,DIV FARMACOL,DEPT FISIOL & FARMACOL,SANTANDER 39011,SPAIN
[3] UNIV AUTONOMA BARCELONA,HOSP SANTA CREU & SANT PAU,FDN GESTIO SANITARIA,AREA INVEST FARMACOL,BARCELONA 08025,SPAIN
关键词
forced swimming test; Wistar-Kyoto rat; Brown Norway way rat; Sprague-Dawley rat; imipramine; 5-HT1; receptor; 5-HT2; beta-adrenoceptor; depression;
D O I
10.1016/S0014-2999(97)01276-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Wistar-Kyoto rats are reported to be very passive in the forced swimming test. In addition, they did not respond to acute administration of either desipramine or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). In the present experiment, it was studied whether or not they respond to acute and chronic administration of imipramine and the possible relationship to down-regulation of beta-adrenoceptors and 5-HT1 and 5-HT2 receptors. Sprague-Dawley and Brown-Norway rats were included in the study as it has been previously demonstrated that the two strains respond to acute desipramine and 8-OH-DPAT administration. Whereas acute administration of imipramine (15 mg/kg, three times in a 21 h period) significantly increased struggling and reduced immobility in Sprague-Dawley and Brown Norway rats, Wistar-Kyoto rats failed to respond to the drug. After chronic treatment with imipramine (13 days plus the acute imipramine treatment at the end of the treatment period), the three strains showed a positive response that was always significantly greater than the response to acute administration, but which was much lower in Wistar-Kyoto than in the other two strains. Down-regulation of both beta-adrenoceptors and 5-HT2 receptors was observed 24 h after the forced swimming test in acutely and chronically imipramine-treated rats of the three strains, except that in Sprague-Dawley rats beta-adrenoceptors did not change after acute imipramine. No significant decrease in 5-HT1 binding sites was observed in any strain. Acute imipramine administration caused a similar anorexia in Wistar-Kyoto as in the other strains and at least the same level of down-regulation of beta-adrenoceptors and 5-HT2 receptor. Tn addition, serum imipramine levels on the day after the last drug administration were higher in Wistar-Kyoto than in the other two strains. All these data suggest that the subsensitivity to imipramine observed in Wistar-Kyoto rats: (i) can not be primarily explained by pharmacokinetic differences, and (ii) does not appear to be related to the monoaminergic systems. Wistar-Kyoto rats might be therefore not only a good animal model of depressive-like (passive) behavior, but also a model of resistance to antidepressants which could be used to investigate the neurobiological basis of such resistance, which is also observed in some depressed patients. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 50 条
  • [1] Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants
    Will, CC
    Aird, F
    Redei, EE
    MOLECULAR PSYCHIATRY, 2003, 8 (11) : 925 - 932
  • [2] Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression
    Dugovic, C
    Solberg, LC
    Redei, E
    Van Reeth, G
    Turek, FW
    NEUROREPORT, 2000, 11 (03) : 627 - 631
  • [3] Are Wistar Kyoto rats a genetic animal model of depression? - Behavioral and pharmacological evaluation
    Yamada, Makiko
    Kawahara, Yukie
    Kaneko, Fumi
    Kawahara, Hirosi
    Nishi, Akinori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 226P - 226P
  • [4] Selectively bred Wistar–Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants
    C C Will
    F Aird
    E E Redei
    Molecular Psychiatry, 2003, 8 : 925 - 932
  • [5] Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression
    Willner, Paul
    Gruca, Piotr
    Lason, Magdalena
    Tota-Glowczyk, Katarzyna
    Litwa, Ewa
    Niemczyk, Monika
    Papp, Mariusz
    BEHAVIOURAL PHARMACOLOGY, 2019, 30 (2-3): : 239 - 250
  • [6] Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats
    Ivarsson, M
    Paterson, LM
    Hutson, PH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 522 (1-3) : 63 - 71
  • [7] Wistar-Kyoto rats as an animal model of anxiety vulnerability: Support for a hypervigilance hypothesis
    McAuley, J. D.
    Stewart, A. L.
    Webber, E. S.
    Cromwell, H. C.
    Servatius, R. J.
    Pang, K. C. H.
    BEHAVIOURAL BRAIN RESEARCH, 2009, 204 (01) : 162 - 168
  • [8] Validation of Wistar-Kyoto rats kept in solitary housing as an animal model for depression using voxel-based morphometry
    Takanobu Yoshii
    Naoya Oishi
    Yasutaka Sotozono
    Anri Watanabe
    Yuki Sakai
    Shunji Yamada
    Ken-Ichi Matsuda
    Masamitsu Kido
    Kazuya Ikoma
    Masaki Tanaka
    Jin Narumoto
    Scientific Reports, 14
  • [9] Validation of Wistar-Kyoto rats kept in solitary housing as an animal model for depression using voxel-based morphometry
    Yoshii, Takanobu
    Oishi, Naoya
    Sotozono, Yasutaka
    Watanabe, Anri
    Sakai, Yuki
    Yamada, Shunji
    Matsuda, Ken-Ichi
    Kido, Masamitsu
    Ikoma, Kazuya
    Tanaka, Masaki
    Narumoto, Jin
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [10] HYPONEOPHAGIA IN WISTAR-KYOTO (WKY) RATS
    PARE, WP
    PHYSIOLOGY & BEHAVIOR, 1994, 55 (05) : 975 - 978